| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-12 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.26 | 6e-11 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.32 | 5e-10 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.32 | 1e-09 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.22 | 7e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |